SE381257B - Sett att framstella rifamycinderivat - Google Patents

Sett att framstella rifamycinderivat

Info

Publication number
SE381257B
SE381257B SE7304223A SE7304223A SE381257B SE 381257 B SE381257 B SE 381257B SE 7304223 A SE7304223 A SE 7304223A SE 7304223 A SE7304223 A SE 7304223A SE 381257 B SE381257 B SE 381257B
Authority
SE
Sweden
Prior art keywords
way
rifamycin derivatives
produce
produce rifamycin
derivatives
Prior art date
Application number
SE7304223A
Other languages
English (en)
Swedish (sv)
Inventor
R Cricchio
G Lancini
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of SE381257B publication Critical patent/SE381257B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7304223A 1972-03-27 1973-03-26 Sett att framstella rifamycinderivat SE381257B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2242172 1972-03-27

Publications (1)

Publication Number Publication Date
SE381257B true SE381257B (sv) 1975-12-01

Family

ID=11196065

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7304223A SE381257B (sv) 1972-03-27 1973-03-26 Sett att framstella rifamycinderivat

Country Status (24)

Country Link
US (1) US3865812A (xx)
JP (1) JPS5142120B2 (xx)
AR (3) AR205434A1 (xx)
AT (1) AT322106B (xx)
AU (1) AU467606B2 (xx)
BE (1) BE797344A (xx)
CA (1) CA999858A (xx)
CH (1) CH567511A5 (xx)
CS (1) CS168642B2 (xx)
DD (1) DD104517A5 (xx)
DE (1) DE2314478C3 (xx)
ES (1) ES413043A1 (xx)
FR (1) FR2182906B1 (xx)
GB (1) GB1388652A (xx)
HU (1) HU167316B (xx)
IE (1) IE37817B1 (xx)
IL (1) IL41532A0 (xx)
LU (1) LU67287A1 (xx)
NL (1) NL171360C (xx)
PL (1) PL89269B1 (xx)
RO (1) RO62882A (xx)
SE (1) SE381257B (xx)
SU (1) SU497777A3 (xx)
ZA (1) ZA73939B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1053787B (it) * 1974-10-29 1981-10-10 Pastori A Macrolidi azotati e loro preparazione
GB1478563A (en) * 1975-03-05 1977-07-06 Lepetit Spa Rifamycin derivatives
DE2728869A1 (de) * 1976-06-25 1977-12-29 Antibiotice Iasi Intreprindere Rifamycinen und verfahren zu deren herstellung
US4179439A (en) * 1977-07-01 1979-12-18 Intreprinderea De Antibiotice Iasi Rifamycins and method for their preparation
JPS6025436B2 (ja) * 1977-07-15 1985-06-18 イントレプリンデレア・デ・アンテイビオテイスイアシ 水溶性リフアマイシン
JPS5419997A (en) * 1977-07-15 1979-02-15 Intorepurinderea De Anteibiote 33formylrifamycin sv derivative
DE2918140C2 (de) * 1979-05-05 1985-02-07 Fresenius AG, 6380 Bad Homburg Dialysator
AU536524B2 (en) * 1979-06-28 1984-05-10 Gruppo Lepetit S.P.A. Water soluble hydrozones of 3-formylifamyan
US4447432A (en) * 1981-11-17 1984-05-08 Farmitalia Carlo Erba S.P.A. Azino rifamycins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR208F (xx) * 1964-07-31
CH489521A (fr) * 1964-07-31 1970-04-30 Lepetit Spa Procédé de préparation d'un dérivé de la rifamycine SV

Also Published As

Publication number Publication date
JPS495998A (xx) 1974-01-19
ES413043A1 (es) 1976-01-16
CH567511A5 (xx) 1975-10-15
DD104517A5 (xx) 1974-03-12
DE2314478B2 (de) 1980-04-30
IL41532A0 (en) 1973-04-30
NL171360C (nl) 1983-03-16
LU67287A1 (xx) 1973-07-13
SU497777A3 (ru) 1975-12-30
IE37817B1 (en) 1977-10-26
AU5342973A (en) 1974-09-19
JPS5142120B2 (xx) 1976-11-13
DE2314478A1 (de) 1973-10-04
HU167316B (xx) 1975-09-27
AR199720A1 (es) 1974-09-23
AT322106B (de) 1975-05-12
BE797344A (fr) 1973-07-16
RO62882A (fr) 1977-11-15
AU467606B2 (en) 1975-12-04
PL89269B1 (xx) 1976-11-30
FR2182906B1 (xx) 1975-10-31
GB1388652A (en) 1975-03-26
ZA73939B (en) 1973-11-28
AR205434A1 (es) 1976-05-07
NL171360B (nl) 1982-10-18
CS168642B2 (xx) 1976-06-29
CA999858A (en) 1976-11-16
IE37817L (en) 1973-09-27
ATA266074A (de) 1975-06-15
NL7304085A (xx) 1973-10-01
AR203839A1 (es) 1975-10-31
US3865812A (en) 1975-02-11
DE2314478C3 (de) 1981-01-08
FR2182906A1 (xx) 1973-12-14

Similar Documents

Publication Publication Date Title
SE7614680L (sv) Sett att framstella nya bensodiazepinderivat
SE415182B (sv) Sett att framstella platinakoordinationsforeningar
SE421615B (sv) Sett att framstella nya tiazolderivat
SE411349B (sv) Sett att framstella nya penicilliner
SE385889B (sv) Sett att framstella morfolinderivat
SE417982B (sv) Sett att framstella cefalosporinforeningar
SE421690B (sv) Sett att framstella bifunktionellt tverbundna insulinderivat
SE8205332D0 (sv) Sett att framstella hoghallfast stalband
SE397830B (sv) Sett att framstella nya bensodioxol-piperazinderivat
SE393377B (sv) Sett att framstella morfolinderivat
SE382215B (sv) Sett att framstella kromanderivat
SE391181B (sv) Sett att framstella kinazolinderivat
SE399255B (sv) Sett att framstella kinazolinonderivat
SE381257B (sv) Sett att framstella rifamycinderivat
SE7603276L (sv) Sett att framstella prostansyraderivat
SE386164B (sv) Sett att framstella nya 2-alkylamino-dihydropyridiner
SE417211B (sv) Sett att framstella indenyl-3-acetoglucuronider
SE420087B (sv) Sett att framstella bifunktionellt tverbundna insulinderivat
SE417981B (sv) Sett att framstella cefalosporinforeningar
SE400078B (sv) Sett att framstella kinazolinonderivat
SE381651B (sv) Sett att framstella karbamater
SE399270B (sv) Sett att framstella spirolaktonsteroider
SE405966B (sv) Sett att framstella peptider
SE397679B (sv) Sett att framstella kinazolinonderivat
SE399712B (sv) Sett att framstella pregnansyraderivat